The global live cell encapsulation market size was USD 269 million in 2020 and is expected to register a CAGR of 3.6% during the forecast period
The global live cell encapsulation market size was USD 269 million in 2020 and is expected to register a CAGR of 3.6% during the forecast period. Key factors, such as increasing awareness about cell encapsulation techniques to treat several chronic disorders and growing need for clinical potency of cell encapsulation techniques, are escalating global market revenue growth.
Live cell encapsulation is a process of combining cells and transferring medicines in human body. This technology encloses live cells in protective capsules. The capsules safeguard live cells from destruction by immune system of recipient’s body and allows blood and nutrients to flow through them and nourish living cells.
Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118254
Rising prevalence of chronic diseases such as cancer has resulted in increasing demand for live cell encapsulation techniques. Moreover, increasing funds by private and public bodies for research and development of enhanced products and government initiatives to support cell encapsulation techniques are boosting market revenue growth. Most market players are also investing in R&D activities to launch novel products and expand their product portfolio. Moreover, increasing research activities are expected to open lucrative growth opportunities for market players going ahead.
Market Dynamics:
Driver: Growing awareness and adoption of advanced drug delivery techniques combined with rising prevalence of chronic diseases
The global market growth is rapidly escalating due to technological advancements in cell encapsulation and increasing demand for live cell encapsulation techniques to treat various chronic and targeted diseases. Increasing awareness among medical practitioners about advantages of this technique is surging revenue growth of the global market. Moreover, growing focus on developing better drug delivery system for disease management is boosting market growth.
Restraint: High costs required for manufacturing products and availability of affordable alternative therapies
The global live cell encapsulation market is expected to show restraining growth between 2021 and 2030 due to increasing investments required for manufacturing live cell encapsulation products. Besides, scarcity of superior quality raw materials and availability of better alternative therapies is expected to impede market growth to a certain extent during the forecast period. In addition, lack of professional assistance for handling these techniques is expected to impact market growth to a certain extent.
Manufacturing Technique Outlook:
Based on manufacturing techniques, the global live cell encapsulation market is segmented into simple dripping, liquid jet break up, electrostatic dripping, coaxial airflow, jet cutting vibrating jet, and rotating disk atomization. The simple dripping segment is projected to account for robust market share during the forecast period. Increasing adoption of simple dripping owing to factors, such as easy and time-efficient, low particle distribution and product biocompatibility, is boosting growth of the live-cell encapsulation market. Besides, electrostatic dripping segment is expected to register highest revenue growth throughout the forecast period. High demand for electrostatic dripping technique is attributed to its beneficial properties such as retention of cell potency and cell viability.
Polymer Type Outlook:
The global market is segmented into alginate, HEMA-MMA, chitosan, cellulose sulfate, siliceous encapsulates, PAN-PVC, and other polymers based on polymer type. The alginate segment dominated other polymer types in the global live cell encapsulated market and is expected to account for significant market share during the forecast period. Alginate is a polysaccharide and most preferred polymer for encapsulating therapeutic agents as it is highly permeable and has high mechanical stability and pore size distribution. These benefits make it more preferable than other polymer segments. On the other hand, the PAN-PVC segment is projected to account for fastest revenue growth during the forecast period owing to factors such as high stability, permeability, and greater biocompatibility.
Related Reports:
- Glycomics/Glycobiology Market: https://qyresearchmedical.com/report/glycomics-glycobiology-market-size-share-and-analysis-by-products-enzymes-kits-reagents-instruments-by-application-drug-discovery-and-development-diagnostics-others-by-end-use-academic-and-research-ins-st-to-2030/118245
- NGS Sample Preparation Market: https://qyresearchmedical.com/report/ngs-sample-preparation-market-size-share-and-analysis-by-product-reagent-workstations-workflow-library-preparation-target-enrichment-quality-control-application-infectious-disease-cancer-diagnostics-t-st-to-2030/118246
Application Outlook:
Based on application, the global market is segmented into cell transplantation, drug delivery, regenerative medicine, research, and probiotics. The drug delivery segment is expected to account for major share in the global market throughout the forecast period. Factors, such as growing usage of live cell encapsulation techniques in drug delivery and increasing occurrence of target diseases, are key factors surging market growth. Benefits, such as enhanced efficacy and decreased toxicity are increasing the demand for live cell encapsulation techniques for drug delivery. The research segment is expected to account for rapid revenue growth between 2021 and 2030 owing to availability of high funds from both public and private sectors to increase cell-based research and develop enhanced products.
Regional Outlook:
North America dominated other regional markets in the global live cell encapsulation market in 2020 and is expected to account for largest market share throughout the forecast period. The U.S. is one of the major contributors in North America. High revenue share is attributed to increasing usage of regenerative medicines, vast healthcare spending, and growing adoption of recent technology. Moreover, increasing funding for research and development by government and healthcare bodies is supporting market growth in this region.
Europe is expected to account for significant revenue growth during the forecast period with UK and Germany being major contributors. Increasing research activities in biotechnology sector, advancement of well-established healthcare systems, and rising prevalence of chronic diseases in the region are some of the significant factors surging growth of the live cell encapsulation market in Europe.
Asia Pacific market is expected to expand at fastest revenue CAGR of 3.4% over the forecast period. Factors such as high focus on improving healthcare services surging market growth in the region. Moreover, government initiatives to provide better healthcare facilities and funds for developing enhanced products are also supporting revenue growth of the live cell encapsulation market.
Competitive Landscape:
The global live cell encapsulation market is highly fragmented and comprises of various regional and global key players. Major companies are involved in developing new strategies and plans, such as mergers and acquisitions, partnerships, and investments in R&D activities, to fulfil growing product demand, increase their product base, as well as gain a firm footing in the global market. BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) are the top three players in the live cell encapsulation market. Other prominent players operating in this market include Sigilon Therapeutics, Inc. (US), Evonik Industries (Germany), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US).
This report offers historical data points and forecasts and revenue growth at a global, regional, and country-level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2018 to 2030. For this study, Reports and Data has segmented the global live cell encapsulation market based on manufacturing technique, polymer type, application, and region:
Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118254
Live Cell Encapsulation Market Report Scope
Segments covered By Based On Manufacturing Technique, Based On Polymer Type, Regional Outlook
By Based On Manufacturing Technique
- Simple Dripping
- Electrostatic Dripping
- Liquid Jet Break Up
- Coaxial Airflow
- Vibrating Jet
- Jet Cutting
- Rotating Disk Atomization
By Based On Polymer Type
- Alginate
- HEMA-MMA
- Chitosan
- Siliceous Encapsulates
- Cellulose Sulfate
- PAN-PVC
- Other Polymers
By Based On Application
- Drug Delivery
- Regenerative medicine
- Cell Transplantation
- Probiotics
- Research
Regional scope
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Buy quantitative research Report at discounted price - USD 1500 https://qyresearchmedical.com/report/checkout/118254/1500
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL - http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/
https://twitter.com/qyresearchmedi